Relapsing and progressive MS: the sex-specific perspective.
Paulus Stefan RommerDavid EllenbergerKerstin HellwigJudith HaasDieter PöhlauAlexander StahmannUwe Klaus Zettlnull nullPublished in: Therapeutic advances in neurological disorders (2020)
Our analysis shows that clinical and demographic data differ more between disease courses than between men and women. For pain, depression and cognitive impairment the female sex is the decisive factor. Whether these factors are responsible for the earlier retirement of females with ROMS is not clear. Appropriate measures for optimization of symptomatic treatment as well as to promote employment should be taken.